Welcome to a new chapter!

Welcome to the January issue of International M&A’s newsletter.

In this issue, we reintroduce our business, answer some frequently asked questions, and share insights into the international markets. We look forward to sharing more in 2020 and welcome your comments.

FAQ Focus

In meetings with many of you, we often receive some of the same questions. The following addresses some of the more frequently asked questions:

What type of businesses do you help?

Our sweet spot is the traditional middle market, B2B business. Currently, we focus on energy, pharma and medical device companies related transactions, where we have experience and resources.  Locations wise, no specific requirements, however, it is generally driven by fundamental market needs.

Who do you work with and in which countries? Do you only work on China-related deals?

As a global company, we conduct business in most countries around the world, as long as it is legally permitted. To date, we have been in discussions to assist companies in over 30 countries. The top 10 countries in which we work include the United States, Canada, United Kingdom, Germany, France, Mexico, China, India, Malaysia, and Indonesia.

 

International Market Update: Things that Caught My Eye

Every day we work with people in all parts of the world. We make it our goal to be aware of the global movement, assist our clients in capturing the right opportunities, and get them to a new foreign market in a smooth and efficient manner. The following news items are of interest to many of our clients.

Pharma:

I-MAB Announces Pricing of U.S. Initial Public Offering. Read more

Energy:

The coal industry is navigating some tumultuous water as banks, insurance and reinsurance companies are refusing to work with coal companies in Europe and the US. Insurance companies have stopped covering roughly US$8.9 trillion of coal investments – more than one-third (37%) of the coal industry’s global assets, and stopped offering reinsurance to 46% of them.

S&P Global Sharply Lowers Its Recovery Values For Coal-Fired Power Projects. Read more

BlackRock is the canary in the coalmine. Its decision to dump coal signals what’s next. Read more

US-China:  

US and China signed a new trade agreement, however will the US and China live up to their end of the agreement? Will the agreement work?

Trump’s ‘Phase One’ Trade Deal With China Won’t Stop Trade Wars From Being the New Normal. Read more

 

Events

JPM No. 38 healthcare conference in San Francisco

It was a pleasure to join hundreds of healthcare executives at the 38th annual J.P. Morgan Healthcare Conference in San Francisco, who presented new ideas and addressed the current state of the industry.

More than 9,000 industry leaders discussed drug pricing, patient affordability and the changing role of the consumer.  Attendees representing 450 emerging fast-growth companies, innovative technology creators, and investment firms had the opportunity to swap insights on strategic plans for 2020 and hear from peers about innovations taking place across different industry segments.

Join the discussion:

Click here to learn more about M&A International. Or contact us to learn how we can assist you in your cross border M&A or divestiture activity.

Share This